PFE Pfizer
Permanent stock page ↗Health Care · S&P 500
Next earnings: Tue 2 Feb 2027 · estimated
What 30 analyst firms say about Pfizer: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
29 rated views · 30 analyst/firm records · 30 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 806
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8027
Recent analyst activity · last 90 days
Our tracked history has 19 reports on PFE from 16 analyst firms in the last 90 days (30 firms in the past year).
Comparing each firm's latest target with its previous one: 8 raised their price target, 1 lowered it, 1 left it unchanged and 4 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Guggenheim raised its target from $31.00 (set 13 Oct 2026) to $33.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Buy | 6 Aug 2026 | 35.00 USD |
| Bank of America Securities | Jason Gerberry | Hold | 10 Jul 2026 | 26.00 USD |
| Barclays | Emily Field | Sell | 14 Aug 2026 | 25.00 USD |
| Berenberg | Kerry Holford | Hold | 7 Oct 2026 | 25.00 USD |
| Bernstein | Courtney Breen | Hold | 23 Jul 2026 | 29.00 USD |
| BMO Capital Markets | Evan Seigerman | Buy | 18 Aug 2026 | 35.00 USD |
| Cantor Fitzgerald | Carter Gould | Hold | 8 Oct 2026 | 28.00 USD |
| CICC | Jin Zhang | Buy | 16 Apr 2026 | 33.00 USD |
| Citigroup | Geoff Meacham | Hold | 29 Apr 2026 | 27.00 USD |
| Daiwa | Narumi Nakagiri | Hold | 18 May 2026 | 27.00 USD |
| DBS | Nico Chen | Buy | 9 Oct 2026 | 35.00 USD |
| DZ Bank | Elmar Kraus | Buy | 21 Jul 2026 | 29.00 USD |
| Erste Group | Hans Engel | Hold | 18 Sep 2026 | — |
| Freedom Capital Markets | Ilya Zubkov | Buy | 1 Jul 2026 | 33.00 USD |
| Goldman Sachs | Asad Haider | Hold | 16 Jul 2026 | 26.00 USD |
| Guggenheim | Vamil Divan | Buy | 13 Oct 2026 | 31.00 USD |
| HSBC | Rajesh Kumar | Hold | 10 Sep 2026 | 30.00 USD |
| Jefferies | Akash Tewari | Buy | 2 Oct 2026 | 36.00 USD |
| JPMorgan | Chris Schott | Hold | 9 Oct 2026 | 30.00 USD |
| Leerink Partners | David Risinger | Hold | 2 Oct 2026 | 28.00 USD |
| Morgan Stanley | Terence Flynn | Hold | 10 Apr 2026 | 28.00 USD |
| RBC Capital Markets | Trung Huynh | Hold | 9 Jun 2026 | 25.00 USD |
| Redburn | Steven K Chesney | Hold | 5 Aug 2026 | 25.00 USD |
| Scotiabank | Louise Chen | Buy | 6 Oct 2026 | 33.00 USD |
| TD Cowen | Steve M Scala | Hold | 7 May 2026 | 30.00 USD |
| UBS | Michael J Yee | Hold | 2 Oct 2026 | 27.00 USD |
| Weiss Ratings | Unnamed analyst | — | 31 Aug 2026 | — |
| Wells Fargo | Mohit Bansal | Hold | 5 Aug 2026 | 28.00 USD |
| Wolfe Research | Alexandria Hammond | Sell | 14 May 2026 | Conflicting reports · excluded |
| Data feed RESEARCH | Research Team | Hold | 24 Feb 2026 | 30.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.